A ribozyme (RZ) gene targeting c-myc mRNA was synthesized and cloned. Cleavage reaction showed that cleavage of the RZ was efficient and specific. The RZ gene-containing retrovirus vector pDOR-RZ was transfected into HCC-9204 hepatoma cells, which constitutively express high levels of c-myc using Lipofectamine. Positively transfected cells were selected using G418. In situ hybridization showed that both pDOR-RZ and pDOR vectors had been integrated into the chromosome of HCC-9204 cells. Dot blot hybridization indicated that expression of the RZ was only evident in pDOR-RZ-transfected HCC-9204 cells. Avidin-biotin complex enzyme-linked immunosorbent assay showed that c-myc expression was down-regulated. Chromatin aggregation into compact masses, cytoplasmic vacuole degeneration, and blurring of cytoplasm structure were observed by transmission electron microscopy in HCC-9204-RZ cells. These results suggest that the use of a c-myc mRNA cleaving enzyme could be most effective in tumor cells that are highly proliferative and constitutively express high levels of c-myc. Cancer Gene Therapy (2000) 7, 407-412
T he c-myc proto-oncogene, whose expression is correlated with the proliferative potential of the cell, is a key transforming agent in the etiology of human cancer. [1] [2] [3] [4] In general, c-myc gene expression has multiple activities, including potentiation and induction of programmed cell death. Amplification and overexpression of c-myc oncogene have been found in hepatoma cells. 5 Inhibition of c-myc expression in hepatoma cells might reduce their malignant potential, induce differentiation, and likely provide new insights for understanding the mechanisms of c-myc oncogene transformation and modulation of gene transcription.
Ribozymes (RZs) are unique RNA molecules with enzymatic activity. They possess the ability to cleave targeted RNA substrates in a site-specific manner. It has been shown that RZs are effective modulators of gene expression, such as activated oncogenes or foreign virus genes. As a new type of catalytic RNA-inhibiting molecule that is different from antisense RNA, RZs can both block and cleave RNA. More importantly, RZs can repeat the function of cleavage, which means that one molecule can destroy many targeted RNA substrates. Once the target has been cleaved, the RZ can dissociate from the cleaved products and repeat the cycle of binding, cleavage, and dissociation. Their simple structure and the ease with which they can be designed makes it possible to provide a new and specific strategy of gene therapy that is applicable to human cancer. 6 -10 In this study, we demonstrate that overexpression of c-myc oncogene can be inhibited by transfecting a c-mycspecific RZ into HCC-9204 hepatoma cells. This was accompanied by decreased cell proliferation and suppression of the hepatoma phenotype.
MATERIALS AND METHODS

RZ constructs
A hammerhead RZ gene targeting c-myc mRNA was designed with the help of a computer (Fig 1) . This RZ possessed the cut-out-by-enzyme sites matching the eukaryotic vector. RZ was synthesized on a Gene Assembler Plus DNA synthesizer (Beckman, Palo Alto, Calif) as single-stranded oligonucleotides encompassing the conserved catalytic motif of a hammerhead RZ, a flanking antisense sequence complementary to a selected sequence in the human c-myc transcripts, and convenient restriction sites, BamHI and EcoRI, for direction cloning. The flanking c-myc sequence was selected based on the presence of the GUC triplet, which serves as a consensus cleavage site for hammerhead RZs, within the targeted c-myc sequence: 5Ј-CG GGATCC GGA GAA GGG TGT CTG ATG AGT CCG TGA GGA CGA AAC CGC AAC GTA GAATTC GC-3Ј. Two single-stranded oligonucleotides were cloned into the HincII site of pUC19. The DNA sequence was confirmed by the dideoxynucleotide chain termination method, using a sequencing kit according to the manufacturer's protocol.
Cleavage reaction in vitro
A RZ gene composed of 51 base pairs was cloned into the BamHI and EcoRI sites of transcription vector pGEM-3zfϪ downstream of the SP6 bacteriophage RNA promoter. c-myc gene containing a cDNA fragment with 675 base pairs within exon 2 was cloned into the EcoRI and HindIII sites of transcription vector pGEM-7zfϩ downstream of the SP6 bacteriophage RNA promoter. RZ and c-myc RNAs were transcribed from EcoRI-linearized DNA templates in the presence of digoxigenin (Dig)-uridine triphosphate (UTP) (3.5 mM/L) using SP6 RNA polymerase according to the manufacturersupplied protocol. The transcription was carried out for 2 hours at 37°C and terminated by the addition of 0.2 M ethylenediaminetetraacetic acid (EDTA). DNA templates were removed by a 15-minute ribonuclease-free deoxyribonuclease I digestion. RNA was precipitated with LiCl and ethanol at Ϫ20°C and dissolved in diethyl pyrocarbonate-treated water. The cleavage reaction was carried out for 2 hours at 50°C in 50 mM tris(hydroxymethyl)aminomethane (Tris)-HCl (pH 8.0) and 20 mM MgCl 2 with a RZ to substrate ratio of 8:1 and terminated by the addition of 0.5 M EDTA. Samples were analyzed by 6% polyacrylamide gel electrophoresis (PAGE) with 8 M urea. The bands were transferred to a nylon membrane and identified with an anti-digoxigenin-alkaline phosphatase coloring system.
RZ expression in cells
For expression of RZ in the hepatoma cell line HCC-9204, a eukaryotic vector was constructed. The RZ gene fragment with cleaving capacity was obtained after treatment with a restriction endonuclease. It was then subcloned into the BamHI and EcoRI sites of the eukaryotic expression vector pDOR, which is a retroviral vector containing a selectable neomycin resistance gene and a simian virus 40 early promoter (Fig 2) . HCC-9204 cell lines were established from a liver tumor of an adult human male. The HCC-9204 cells were maintained in RPMI 1640 medium containing 10% fetal bovine sera and supplemented with penicillin (100 g/mL) and streptomycin (100 g/mL). The recombinant retroviral vector pDOR-RZ was transfected into HCC-9204 cells by Lipofectamine according to the manufacturer-provided protocol using 2 g of vector DNA and 10 L of Lipofectamine. Positively transfected HCC-9204-RZ cell clones were selected out in growth medium containing 500 g/mL Geneticin (G418) for 2-3 weeks. Drugresistant cells were grown and used for further analysis.
In situ hybridization and RNA dot blot analysis of RZ expression in HCC-9204 cells
A neo-cDNA probe and a c-myc mRNA probe were labeled with Dig-UTP and analyzed by established nick translation and in vitro transcription procedures. Cells were cultured and fixed on slides with formaldehyde. Endogenous peroxidase was inhibited by treating the cells with 0.2 M HCl for 30 minutes at room temperature and incubated with 4 L/mL proteinase K for 15 minutes at 37°C, followed by washing with 2ϫ standard saline citrate (SSC) and phosphate-buffered saline. This was followed by the addition of prehybridization solution (4ϫ SSC, 50% formamide, 1ϫ Denhardt's, and 0.5 mg/mL salmon sperm DNA) for 1 hour at room temperature. After discarding the prehybridization solution, a stained hybridization solution (2ϫ SSC, 50% formamide, 1ϫ Denhardt's, 0.5 mg/mL salmon sperm DNA, and 0.5 g/mL Dig-labeled neo-cDNA probe) was added and incubated at 55°C for 16 hours. The slides were then washed with SSC and incubated with blocking solution for 30 minutes (2% sera, 0.3% Triton X-100) at room temperature. Afterward, the slides were incubated at 4°C overnight with anti-digoxigenin-alkaline phosphatase and then stained with a solution containing 100 mM Tris-HCl, 100 mM NaCl, 50 mM MgCl 2 , 0.45% nitroblue tetrazolium, and 0.35% 5-bromo-4-chloro-3-indolyl phosphate (pH 9.5). Total cellular RNA was isolated by a single-step procedure using guanidine thiocyanate and phenol/chloroform. RNA samples were denatured by a mixture containing 34% glyoxal and 0.2 M phosphate buffer at 50°C (for a 1-hour incubation), loaded onto the nitrocellulose membrane, and hybridized with the c-myc mRNA probe at 42°C for 20 hours; next, the filters were washed with an SSC-sodium dodecyl sulfate solution.
Cell proliferation analysis c-Myc protein expression was measured with an avidin-biotin complex (ABC) enzyme-linked immunosorbent assay (ELISA) kit using 96-well culture plates. Cell proliferation was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-dimethyltetrazolium Figure 1 . Primary sequence of the hammerhead RZ designed to cleave the c-myc mRNA at the GUC site and the expected secondary structure formed with the substrate. Computer analysis of secondary RNA structure and homology showed that the cleavage target site was suitable and no other gene mRNA had the base sequence complementary to the designed RZ. The active cleavage sequences of the RZ contained 24 bases and the flanking sequences at the 5Ј and 3Ј end of hammerhead structure were 11 and 10 bases, respectively, that were complementary to the c-myc gene sequence. For the convenience of cloning, the 5Ј and 3Ј ends contain a BamHI and EcoRI restriction endonuclease site, respectively. Two additional protective bases were added on each side of the RZ. The RZ C1 and C2 chain sequences are: C1, 5Ј-CGGGATCCGGAGAAGGGT-GTCTGAGTCCGTGAGGACGAAACCGCAACGTAGAATTCGC3Ј; C2, 3Ј-GCCCTAGGCCTCTTCCCACAGACTACTCAGGCACTCCTGC-TTTGGCGTTGCATCTTAAGCG-5Ј.
bromide (MTT) assay using 96-well culture plates. Cells were seeded at 1 ϫ 10 3 cells/well and grown for 24 hours, followed by detection using MTT (5 g/mL) at 37°C for 4 hours; next, dimethylsulfoxide was added. Morphologic changes were observed by transmission electron microscopy.
RESULTS
Construction of cloning vector pUC19-RZ
The hammerhead RZ gene was successfully cloned into the HincII site of pUC19. This gene complex was treated with restriction endonuclease BamHI and EcoRI and analyzed by PAGE. The RZ gene sequence was confirmed by the dideoxynucleotide chain termination method (data not shown).
Cleavage reaction of RZ in vitro Transcription vectors PGEM-3zf
Ϫ -RZ and PGEM-7zf
ϩ -c-myc were constructed as templates. After treatment with RNA polymerase, RZ and c-myc RNA were obtained. The mixtures were combined and analyzed for cleavage of c-myc. The cleavage reaction showed that cleavage of the RZ was efficient and specific, with the expected fragment observed at 531 nucleotide (nt) (Fig  3) . Thin-layer scan of the c-myc mixture and the RZ-cmyc mixture showed that the precleavage numerical value of the substrate was 12,023.960 and the postcleavage numerical value of the substrate was 1,107.457, indicating that the cleavage efficiency is ϳ90%.
Expression of RZ in HCC-9204 cells
Restriction enzyme analysis showed that the RZ gene had been inserted correctly between the BamHI and EcoRI sites of the eukaryotic expression vector pDOR. pDOR-RZ and pDOR were transfected into the HCC-9204 cells using Lipofectamine. Stable expression cell lines were selected. In situ hybridization showed that both pDOR-RZ-and pDOR-transfected cell lines take up the dye and show the blue color (positive hybridizing signals), demonstrating that both the pDOR-RZ and pDOR vectors have been integrated into the chromosome of HCC-9204 cells (Fig 4) . Dot blot hybridization indicated that expression of the RZ was only evident in pDOR-RZ-transfected HCC-9204 cells (Fig 5) .
Effect of RZ on HCC-9204 cell proliferation
Expression of c-myc protein on the HCC-9204-RZ cells was inhibited, as demonstrated by the ABC ELISA method (P Ͻ .01, Table 1 ). An MTT assay showed that proliferation of HCC-9204-RZ cells was reduced markedly (P Ͻ .01, Table 2 ). Transmission electron microscopy demonstrated the morphologic changes of RZgenerating HCC-9204 cells, which are manifested by chromatin aggregation into compact masses, cytoplasmic vacuole degeneration, and blurring of the cytoplasmic structure when compared with HCC-9204 cells (Fig 6) .
DISCUSSION
A contemporary approach for modulating gene expression is the use of RZs. RZs can cleave targeted RNA substrates in a site-specific manner and are effective modulators of gene expression. The hypothesis that RZs could be used as agents for inactivating or altering the flow of genetic information led to the suggestion that they could be used as therapeutic agents, especially because of their capacity to cleave oncogenes. Hammerhead RZs have thus far been shown to cleave a number of genes related to proliferation, infection with retroviruses, and drug resistance. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] Among them, synthetic hammerhead RZs have been found to cleave mRNA substrates associated with Ha-ras in three tumor cell lines. This has resulted in a suppression of the transformation and tumorigenicity of these cell lines. 24 The transfection of a hammerhead RZ into myelomonocytic cells that specifically cleaves v-myc caused a reduction in v-myc expression that was associated with a diminution in dexamethasone-induced apoptosis. 25 NIH3T3 cells containing aberrant epidermal growth factor receptor cotransfected with a hammerhead RZ that cleaves the aberrant receptor mRNA substrate showed a decrease in the growth of tumors formed by the cotransfected cells inoculated into nude mice when compared with the parent cells or with cells containing the disabled RZ. RZs have altered the phenotypes of target cell lines in culture and in murine model systems. 19 The sequencespecific enzymatic activity and the relative ease with which a RZ can be designed have substantial advantages that may translate into low side effects and high potency. RZs are applicable in principle to any disease in which a specific protein or virus can be linked to disease etiology.
Recent studies have defined the molecular basis of cell growth and differentiation. The proliferation and In situ hybridization. Cells were cultured and fixed on slides with formaldehyde. Endogenous peroxidase was inhibited by treating the cells with 0.2 M HCl and 4 L/mL proteinase K. This was followed by adding prehybridization solution for 1 hour at room temperature. After discarding the prehybridization solution, a stained hybridization solution was added and incubated at 55°C for 16 hours. The slides were then washed with SSC and incubated with blocking solution for 30 minutes (2% sera, 0.3% Triton X-100) at room temperature. Afterward, the slides were incubated at 4°C overnight with anti-digoxigenin-alkaline phosphatase and subsequently stained with 0.45% nitroblue tetrazolium and 0. differentiation of normal cells can be initiated by signal transduction cascades and regulated by a balance between the action of proto-oncogenes and suppressor genes. Among the proto-oncogene products, the nuclear oncogene protein c-myc plays an important role in the malignant transformation and proliferation of human cells. 26 -28 Expression of activated c-myc oncogene has been shown previously to stimulate proliferation and induce malignant transformation in a variety of cell types. The data presented in this study demonstrate that it is possible to design a RZ against activated c-myc mRNA to reverse the malignant phenotype in HCC-9204 hepatoma cells.
The c-myc protein structure is organized into three functional regions: 150 aa from the N terminus can function as a transcriptional activation domain, which is essential for gene activation and transformation; the middle region contains a nonspecific binding domain and nuclear localization sequences or signals; a total of 100 aa from the C terminus is the contiguous basic region, helix-loop-helix region, and leucine zipper. 5 Contiguous basic region-helix-loop-helix-leucine zipper motifs are characteristic of transcription factors that bind to specific DNA sequences. In this study, the transcription activation domain was chosen as a cleavage site. Computer analysis of secondary RNA structure and homology showed that the cleavage target site was suitable and no other gene mRNA had the base sequence complementary to the designed RZ. c-Myc expression is found to effectively modulate cell proliferation and reverse the malignant phenotype. Overexpression of c-myc mRNA cleaving enzyme of melanoma cells causes an increase in doubling time, tritiated thymidine uptake, diminution in colonies, and an increase in melanin content when compared with normal cells. 24 These findings are consistent with those observed in the HCC-9204 cell line transfected with c-myc mRNA cleaving enzyme. Antisense oligonucleotide c-myc constructs have been used against activated c-myc expression. It was demonstrated that these constructs reduced c-myc gene expression and inhibited malignant cell proliferation. 29 -31 Although similar results were obtained with these antisense constructs, RZs offer advantages over the use of antisense constructs in that they have the potential for operating as antisense molecules as well as catalytic RNAs. In addition, their molecular size does not pose the same structural limitations as the larger antisense constructs, and they are more resistant to attack by nucleases than antisense constructs because of their stable secondary structure.
The responsiveness of the HCC-9204 hepatoma cell line to overexpression of the c-myc mRNA cleaving enzyme leads to the suggestion that choice of the target gene may be a critical factor in cancer therapy. These target genes could serve an important function if they are involved in proliferation and can be controlled by the presence of a specific mRNA cleaving enzyme. The fact that the HCC-9204 cell line has a constitutively high expression of c-myc allowed for specific targeting by a c-myc mRNA cleaving enzyme that resulted in changes in overall cell proliferation and transformation. Perhaps the use of a c-myc mRNA cleaving enzyme would be most effective in tumor cells that are highly proliferative and constitutively express high levels of c-myc. In addition, this study suggests the possibility of anti-oncogene RZs as tumor suppressors and inhibitors of malignant phenotype. This would add c-myc mRNA cleaving enzyme to the growing list of agents that inhibit malignant phenotypes. 
